Cargando…
The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
It is under debate whether healthcare costs related to death and in life years gained (LysG) due to life saving interventions should be included in economic evaluations. We estimated the impact of including these costs on cost-effectiveness of cancer screening. We obtained health insurance, home car...
Autores principales: | de Kok, I M C M, Polder, J J, Habbema, J D F, Berkers, L-M, Meerding, W J, Rebolj, M, van Ballegooijen, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676546/ https://www.ncbi.nlm.nih.gov/pubmed/19367281 http://dx.doi.org/10.1038/sj.bjc.6605018 |
Ejemplares similares
-
Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009
por: Hwang, Inuk, et al.
Publicado: (2016) -
The use and costs of Medicare services in the last 2 years of life
por: Lubitz, James, et al.
Publicado: (1984) -
The healthcare costs of heart failure during the last five years of life: A retrospective cohort study
por: Hollingworth, William, et al.
Publicado: (2017) -
Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands
por: Schneider, Paul P., et al.
Publicado: (2020) -
Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland
por: Panczak, Radoslaw, et al.
Publicado: (2018)